Home / WorldWorldAntara NewsWorldAntara News·Sep 16, 2026·1 min readQurCan Therapeutics Enters Strategic Research and Collaboration Agreement with Lilly to Advance Nucleic Acid Therapies…-QurCan Therapeutics (“QurCan”), a biotechnology company pioneering non-viral, polymer-lipid nanoparticle ...View original source — Antara News ↗ShareCopy linkShare on XShare on FacebookRelated storiesTechnologyEuronewsTechnologySep 16, 2026 · 1 minDanish pharma giant Novo to use Anthropic’s Claude to advance AI drug discoveryEuronewsTechnologyTimes of IsraelTechnologySep 8, 2026 · 1 minAs investors dry up, national biotech hub aims to transfuse early-stage drug fundingTimes of IsraelHealthSouth China Morning PostHealthSep 16, 2026 · 1 minGSK licenses Chinese firm’s cancer drug in US$750 million dealSouth China Morning PostTechnologyThe Next WebTechnologySep 16, 2026 · 1 minNovo will test Anthropic’s Claude Science to speed up drug discoveryThe Next Web
TechnologyEuronewsTechnologySep 16, 2026 · 1 minDanish pharma giant Novo to use Anthropic’s Claude to advance AI drug discoveryEuronews
TechnologyTimes of IsraelTechnologySep 8, 2026 · 1 minAs investors dry up, national biotech hub aims to transfuse early-stage drug fundingTimes of Israel
HealthSouth China Morning PostHealthSep 16, 2026 · 1 minGSK licenses Chinese firm’s cancer drug in US$750 million dealSouth China Morning Post
TechnologyThe Next WebTechnologySep 16, 2026 · 1 minNovo will test Anthropic’s Claude Science to speed up drug discoveryThe Next Web